INS and diabetes mellitus: In both mice with streptozotocin-induced diabetes and db/db mice, cAng-(1–7) caused an increase in insulin levels and reduced blood glucose levels, indicating the therapeutic potential that cAng-(1–7) has for treating type 1 and 2 diabetes (Kuipers et al., 2019).